| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Païkan Marcagg. Cerebellar endocannabinoids: retrograde signaling from purkinje cells. Cerebellum (London, England). vol 14. issue 3. 2016-05-02. PMID:25520276. |
the cerebellar cortex exhibits a strikingly high expression of type 1 cannabinoid receptor (cb1), the cannabinoid binding protein responsible for the psychoactive effects of marijuana. |
2016-05-02 |
2023-08-13 |
Not clear |
| K C Koh, W Y Lee, Z W Eh, I Nor Julaika, P S Tee, O Azizon, M Thilageswar. Efavirenz does not cause false-positive urine cannabis test in HIV-infected patients on Highly Active Anti-Retroviral Therapy. The Medical journal of Malaysia. vol 68. issue 3. 2016-04-23. PMID:23749016. |
we investigated if the urine of hiv-infected patients on efavirenz caused a positive urine cannabis test using the axsym cannabinoids assay®. |
2016-04-23 |
2023-08-12 |
Not clear |
| K C Koh, W Y Lee, Z W Eh, I Nor Julaika, P S Tee, O Azizon, M Thilageswar. Efavirenz does not cause false-positive urine cannabis test in HIV-infected patients on Highly Active Anti-Retroviral Therapy. The Medical journal of Malaysia. vol 68. issue 3. 2016-04-23. PMID:23749016. |
efavirenz does not cause false positive urine cannabis test with the axsym cannabinoids assay®. |
2016-04-23 |
2023-08-12 |
Not clear |
| Divya Ramesh, Joel E Schlosburg, Jason M Wiebelhaus, Aron H Lichtma. Marijuana dependence: not just smoke and mirrors. ILAR journal. vol 52. issue 3. 2016-04-22. PMID:23382144. |
in addition, we review research evaluating potential pharmacotherapies (e.g., thc, a variety of antidepressant drugs, and lithium) to reduce cannabis withdrawal responses and examine how expanded knowledge about the regulatory mechanisms in the endocannabinoid system may lead to promising new therapeutic targets. |
2016-04-22 |
2023-08-12 |
Not clear |
| Cristoforo Silvestri, Debora Paris, Andrea Martella, Dominique Melck, Irene Guadagnino, Mike Cawthorne, Andrea Motta, Vincenzo Di Marz. Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. Journal of hepatology. vol 62. issue 6. 2016-04-22. PMID:25595882. |
recent evidence suggests that the cannabinoids Δ(9)-tetrahydrocannabivarin (thcv) and cannabidiol (cbd) improve insulin sensitivity; we aimed at studying their effects on lipid levels. |
2016-04-22 |
2023-08-13 |
human |
| Jessica Pandohee, Brendan J Holland, Bingshan Li, Takuya Tsuzuki, Paul G Stevenson, Neil W Barnett, James R Pearson, Oliver A H Jones, Xavier A Conla. Screening of cannabinoids in industrial-grade hemp using two-dimensional liquid chromatography coupled with acidic potassium permanganate chemiluminescence detection. Journal of separation science. vol 38. issue 12. 2016-04-21. PMID:25845561. |
the analysis of cannabis plants/products in both pharmacological and forensic studies often requires the separation of compounds of interest and/or accurate identification of the whole cannabinoid profile. |
2016-04-21 |
2023-08-13 |
Not clear |
| Xavier Viñals, Estefanía Moreno, Laurence Lanfumey, Arnau Cordomí, Antoni Pastor, Rafael de La Torre, Paola Gasperini, Gemma Navarro, Lesley A Howell, Leonardo Pardo, Carmen Lluís, Enric I Canela, Peter J McCormick, Rafael Maldonado, Patricia Robled. Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. PLoS biology. vol 13. issue 7. 2016-04-12. PMID:26158621. |
activation of cannabinoid cb1 receptors (cb1r) by delta9-tetrahydrocannabinol (thc) produces a variety of negative effects with major consequences in cannabis users that constitute important drawbacks for the use of cannabinoids as therapeutic agents. |
2016-04-12 |
2023-08-13 |
mouse |
| David H Epstein, Kenzie L Presto. No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper. The American journal on addictions. vol 24. issue 4. 2016-04-11. PMID:25846329. |
to support medication development with cannabinoids, smoked cannabis has been said to alleviate symptoms of opioid withdrawal. |
2016-04-11 |
2023-08-13 |
Not clear |
| Peter B Chase, Jeff Hawkins, Jarrod Mosier, Ernest Jimenez, Keith Boesen, Barry K Logan, Frank G Walte. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs. Clinical toxicology (Philadelphia, Pa.). vol 54. issue 1. 2016-04-11. PMID:26653952. |
differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs. |
2016-04-11 |
2023-08-13 |
Not clear |
| Peter B Chase, Jeff Hawkins, Jarrod Mosier, Ernest Jimenez, Keith Boesen, Barry K Logan, Frank G Walte. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs. Clinical toxicology (Philadelphia, Pa.). vol 54. issue 1. 2016-04-11. PMID:26653952. |
these changes present challenges to law enforcement drug recognition experts (dres) who determine whether drivers are impaired by synthetic cannabinoids or marijuana, as well as to clinical toxicologists who care for patients with complications from synthetic cannabinoids and marijuana. |
2016-04-11 |
2023-08-13 |
Not clear |
| Peter B Chase, Jeff Hawkins, Jarrod Mosier, Ernest Jimenez, Keith Boesen, Barry K Logan, Frank G Walte. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs. Clinical toxicology (Philadelphia, Pa.). vol 54. issue 1. 2016-04-11. PMID:26653952. |
our goal was to compare what effects synthetic cannabinoids and marijuana had on performance and behavior, including driving impairment, by reviewing records generated by law enforcement dres who evaluated motorists arrested for impaired driving. |
2016-04-11 |
2023-08-13 |
Not clear |
| Gareth Pryce, Dieter R Riddall, David L Selwood, Gavin Giovannoni, David Bake. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:25537576. |
although there is limited evidence that the cannabinoids from cannabis are having significant immunosuppressive activities that will influence relapsing autoimmunity, we and others can experimentally demonstrate that they may limit neurodegeneration that drives progressive disability. |
2016-04-01 |
2023-08-13 |
mouse |
| Valerio Chiurchiù, Alessandro Leuti, Mauro Maccarron. Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:25601726. |
a growing body of evidence suggests that cannabis sativa-derived phytocannabinoids, as well as synthetic cannabinoids, are endowed with significant immunoregulatory and anti-inflammatory properties, both in peripheral tissues and in the cns, through the activation of cannabinoid receptors. |
2016-04-01 |
2023-08-13 |
Not clear |
| Elizabeth E Zumbrun, Jessica M Sido, Prakash S Nagarkatti, Mitzi Nagarkatt. Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:25618446. |
epigenetic regulation of immunological alterations following prenatal exposure to marijuana cannabinoids and its long term consequences in offspring. |
2016-04-01 |
2023-08-13 |
human |
| Elizabeth E Zumbrun, Jessica M Sido, Prakash S Nagarkatti, Mitzi Nagarkatt. Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:25618446. |
the cannabinoids present in marijuana have been shown to be immunosuppressive, yet the effect of prenatal exposure to cannabinoids on the immune system of the developing fetus, its long term consequences during adult stage of life, and transgenerational effects have not been well characterized. |
2016-04-01 |
2023-08-13 |
human |
| Toby K Eisenstein, Joseph J Meissle. Effects of Cannabinoids on T-cell Function and Resistance to Infection. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:25876735. |
the paper considers the immune modulating capacity of marijuana, of ∆(9)-thc extracted from the marijuana plant, and synthetic cannabinoids. |
2016-04-01 |
2023-08-13 |
Not clear |
| Weimin Chen, Robert B Crawford, Barbara L F Kaplan, Norbert E Kaminsk. Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:25900076. |
approximately 25 % of hiv patients use marijuana for its putative therapeutic benefit; however, it is unknown how cannabinoids affect the immune status of hiv patients. |
2016-04-01 |
2023-08-13 |
mouse |
| Sean D McAllister, Liliana Soroceanu, Pierre-Yves Despre. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:25916739. |
as a therapeutic agent, most people are familiar with the palliative effects of the primary psychoactive constituent of cannabis sativa (cs), Δ(9)-tetrahydrocannabinol (thc), a molecule active at both the cannabinoid 1 (cb1) and cannabinoid 2 (cb2) receptor subtypes. |
2016-04-01 |
2023-08-13 |
Not clear |
| Sean D McAllister, Liliana Soroceanu, Pierre-Yves Despre. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:25916739. |
for example, the second most abundant cannabinoid in cs is the non-psychoactive cannabidiol (cbd). |
2016-04-01 |
2023-08-13 |
Not clear |
| Guy A Cabral, Thomas J Rogers, Aron H Lichtma. Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 10. issue 2. 2016-04-01. PMID:26054900. |
the major psychoactive phytocannabinoid found in cannabis ∆(9)-tetrahydrocannabinol (thc) produces the majority of its pharmacological effects through two cannabinoid receptors, termed cb1 and cb2. |
2016-04-01 |
2023-08-13 |
human |